Literature DB >> 2547475

Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle.

K Ogawa1, K Takagi, T Satake.   

Abstract

1. Four 3-alkylxanthines (3-methylxanthine, 3-n-propylxanthine (enprofylline), 3-n-butylxanthine and 3-iso-butylxanthine) and four 1-methyl-3-alkylxanthines (1-methyl-3-methylxanthine (theophylline), 1-methyl-3-n-propylxanthine, 1-methyl-3-n-butylxanthine and 1-methyl-3-iso-butylxanthine (IBMX], were compared in terms of cyclic AMP phosphodiesterase (PDE) inhibition and trachealis muscle relaxation. The relationship between xanthine structure and cyclic AMP PDE inhibition was also studied. 2. Xanthine induced relaxation of guinea-pig isolated trachealis muscle was measured against spontaneous tone. 3. The four 1-methyl-3-alkylxanthines were each significantly more potent than the corresponding 3-alkylxanthines in relaxing the isolated trachealis muscle. The 1-methyl-3-alkylxanthines were similarly more potent than the corresponding 3-alkyl derivatives in inhibiting low Km cyclic AMP PDE. There was a strong positive correlation between low Km cyclic AMP PDE inhibition and the tracheal smooth muscle relaxation evoked by the xanthine derivatives. 4. Since methylation of the 1-position of each 3-alkylxanthine increased the potency of the derivative in inhibiting low Km cyclic AMP PDE and in relaxing trachealis muscle and since a strong positive correlation was observed between the relaxant EC50 and the Ki value of each xanthine derivative, it is suggested that low Km cyclic AMP PDE inhibition by xanthines plays an important role in their tracheal relaxant effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547475      PMCID: PMC1854524          DOI: 10.1111/j.1476-5381.1989.tb11983.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle.

Authors:  S Katsuki; F Murad
Journal:  Mol Pharmacol       Date:  1977-03       Impact factor: 4.436

2.  A comparison of the bronchodilator activity of some 1- and 7-substituted xanthines in the guinea pig.

Authors:  J K FERGUSON; J D MCCOLL; J M PARKER
Journal:  J Pharmacol Exp Ther       Date:  1956-11       Impact factor: 4.030

3.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

4.  cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation.

Authors:  D J Newman; D F Colella; C B Spainhour; E G Brann; B Zabko-Potapovich; J R Wardell
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

5.  Effects of verapamil on the contractions of guinea-pig tracheal muscle induced by Ca, Sr and Ba.

Authors:  K Baba; M Kawanishi; T Satake; T Tomita
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 6.  Phosphodiesterase inhibition and theophylline.

Authors:  H Bergstrand
Journal:  Eur J Respir Dis Suppl       Date:  1980

Review 7.  The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics.

Authors:  C G Persson
Journal:  Agents Actions Suppl       Date:  1983

8.  Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.

Authors:  E Lunell; N Svedmyr; K E Andersson; C G Persson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

10.  Stimulation of release of adrenal catecholamine by adenosine 3':5'-cyclic monophosphate and theophylline in the absence of extracellular Ca 2+ .

Authors:  M J Peach
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

View more
  2 in total

1.  Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells.

Authors:  Jiro Sakai; Masahiro Oike; Masakazu Hirakawa; Yushi Ito
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

Review 2.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.